Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Mcnulty, Shannon ^a   Bornmann, William ^b   Schriewer, Jill ^c   Werner, Chas ^c   Smith, Scott K ^d   Olson, Victoria A ^d   Damon, Inger K ^d   Buller, R Mark ^c   Heuser, John ^e   Kalman, Daniel ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P85; GREEN FLUORESCENT PROTEIN; PROTEIN KINASE INHIBITOR; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION; IC 50; MOUSE; NONHUMAN; VACCINIA VIRUS; VIRION; VIRUS MORPHOGENESIS; VIRUS PLAQUE; VIRUS STRAIN; WESTERN BLOTTING; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MORPHOGENESIS; PROTEIN TRANSPORT; ULTRASTRUCTURE;

ANIMALIA; POXVIRIDAE; VACCINIA VIRUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE; GREEN FLUORESCENT PROTEINS; HUMANS; INHIBITORY CONCENTRATION 50; MORPHOGENESIS; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; VACCINIA VIRUS; VIRAL PROTEINS; VIRION;

EID: 77956296919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010884     Document Type: Article

References (108)

1. Fenner FH, Ainslie D, Arita I, Jezek Z, Ladnyi I, et al. (1988) Smallpox and its Eradication. Geneva.
2. Gur I (2008) The epidemiology of Molluscum contagiosum in HIV-seropositive patients: a unique entity or insignificant finding? Int J STD AIDS 19: 503-506.
3. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, et al. (2004) The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 350: 342-350.
4. Rimoin AW, Kisalu N, Kebela-Ilunga B, Mukaba T, Wright LL, et al. (2007) Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerg Infect Dis 13: 934-937.
5. Rodriguez JR, Risco C, Carrascosa JL, Esteban M, Rodriguez D (1997) Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol 71: 1821-1833.
6. Hollinshead M, Vanderplasschen A, Smith GL, Vaux DJ (1999) Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol 73: 1503-1517.
7. Sodeik B, Doms RW, Ericsson M, Hiller G, Machamer CE, et al. (1993) Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J Cell Biol 121: 521-541.
8. Risco C, Rodriguez JR, Lopez-Iglesias C, Carrascosa JL, Esteban M, et al. (2002) Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly. J Virol 76: 1839-1855.
9. Armstrong JA, Metz DH, Young MR (1973) The mode of entry of vaccinia virus into L cells. J Gen Virol 21: 533-537.
10. Carter GC, Law M, Hollinshead M, Smith GL (2005) Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol 86: 1279-1290.
11. Chang A, Metz DH (1976) Further investigations on the mode of entry of vaccinia virus into cells. J Gen Virol 32: 275-282.
12. Dales S (1963) The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid. J Cell Biol 18: 51-72.
13. Smith GL, Vanderplasschen A, Law M (2002) The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83: 2915-2931.
14. Vanderplasschen A, Hollinshead M, Smith GL (1998) Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol 79 (Pt4): 877-887.
15. Ichihashi Y (1996) Extracellular enveloped vaccinia virus escapes neutralization. Virology 217: 478-485.
16. Law M, Carter GC, Roberts KL, Hollinshead M, Smith GL (2006) Ligandinduced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci USA 103: 5989-5994.
17. Condit RC, Moussatche N, Traktman P (2006) In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res 66: 31-124.
18. Kajioka R, Siminovitch L, Dales S (1964) The Cycle of Multiplication of Vaccinia Virus in Earle's Strain L Cells. Ii. Initiation of DNA Synthesis and Morphogenesis. Virology 24: 295-309.
19. Dales S, Mosbach EH (1968) Vaccinia as a model for membrane biogenesis. Virology 35: 564-583.
20. Senkevich TG, Weisberg AS, Moss B (2000) Vaccinia virus E10R protein is associated with the membranes of intracellular mature virions and has a role in morphogenesis. Virology 278: 244-252.
21. Blouch RE, Byrd CM, Hruby DE (2005) Importance of disulphide bonds for vaccinia virus L1R protein function. Virol J 2: 91.
22. Unger B, Traktman P (2004) Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions. J Virol 78: 8885-8901.
23. Betakova T, Wolffe EJ, Moss B (1999) Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase. J Virol 73: 3534-3543.
24. Punjabi A, Traktman P (2005) Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis. J Virol 79: 2171-2190.
25. Byrd CM, Hruby DE (2006) Vaccinia virus proteolysis-a review. Rev Med Virol 16: 187-202.
26. White CL, Weisberg AS, Moss B (2000) A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis. J Virol 74: 9175-9183.
27. Senkevich TG, White CL, Koonin EV, Moss B (2000) A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation. Proc Natl Acad Sci USA 97: 12068-12073.
28. Senkevich TG, White CL, Weisberg A, Granek JA, Wolffe EJ, et al. (2002) Expression of the vaccinia virus A2.5L redox protein is required for virion morphogenesis. Virology 300: 296-303.
29. Senkevich TG, White CL, Koonin EV, Moss B (2002) Complete pathway for protein disulfide bond formation encoded by poxviruses. Proc Natl Acad Sci USA 99: 6667-6672.
30. Tooze J, Hollinshead M, Reis B, Radsak K, Kern H (1993) Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur J Cell Biol 60: 163-178.
31. Schmelz M, Sodeik B, Ericsson M, Wolffe EJ, Shida H, et al. (1994) Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 68: 130-147.
32. Ploubidou A, Moreau V, Ashman K, Reckmann I, Gonzalez C, et al. (2000) Vaccinia virus infection disrupts microtubule organization and centrosome function. Embo J 19: 3932-3944.
33. Ward BM (2005) Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J Virol 79: 4755-4763.
34. Sanderson CM, Hollinshead M, Smith GL (2000) The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol 81: 47-58.
35. Husain M, Moss B (2001) Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles. J Virol 75: 7528-7542.
36. Earley AK, Chan WM, Ward BM (2008) The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J Virol 82: 2161-2169.
37. Hirsch E, Costa C, Ciraolo E (2007) Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. J Endocrinol 194: 243-256.
38. Hawkins PT, Anderson KE, Davidson K, Stephens LR (2006) Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans 34: 647-662.
39. Berridge MJ, Irvine RF (1989) Inositol phosphates and cell signalling. Nature 341: 197-205.
40. Vieira OV, Botelho RJ, Rameh L, Brachmann SM, Matsuo T, et al. (2001) Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J Cell Biol 155: 19-25.
41. Backer JM (2008) The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem J 410: 1-17.
42. Franke TF (2008) Intracellular signaling by Akt: bound to be specific. Sci Signal 1: p e29.
43. Knight ZA, Shokat KM (2007) Chemically targeting the PI3K family. Biochem Soc Trans 35: 245-249.
44. Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, et al. (2006) A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125: 733-747.
45. Ruckle T, Schwarz MK, Rommel C (2006) PI3Kgamma inhibition: towards an 'aspirin of the 21st century'? Nat Rev Drug Discov 5: 903-918.
46. Jiang BH, Liu LZ (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784: 150-158.
47. Buchkovich NJ, Yu Y, Zampieri CA, Alwine JC (2008) The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signaling pathway. Nat Rev Microbiol 6: 266-275.
48. Soares JA, Leite FG, Andrade LG, Torres AA, De Sousa LP, et al. (2009) Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J Virol 83: 6883-6899.
49. Cooray S (2004) The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J Gen Virol 85: 1065-1076.
50. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, et al. (2002) Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 22: 965-977.
51. Brachmann SM, Yballe CM, Innocenti M, Deane JA, Fruman DA, et al. (2005) Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Mol Cell Biol 25: 2593-2606.
52. Reeves PM, Bommarius B, Lebeis S, McNulty S, Christensen J, et al. (2005) Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat Med 11: 731-739.
53. Rueckle TJ, Xuiliang, Gaillard P, Church D, Vallotton T (2005) Azolidinolonevinyl Fused-Benzene Derivatives. In: WIPO, editor.
54. Mercer J, Helenius A (2008) Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320: 531-535.
55. Townsley AC, Weisberg AS, Wagenaar TR, Moss B (2006) Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J Virol 80: 8899-8908.
56. Ward BM, Moss B (2001) Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J Virol 75: 11651-11663.
57. Geada MM, Galindo I, Lorenzo MM, Perdiguero B, Blasco R (2001) Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J Gen Virol 82: 2747-2760.
58. Szajner P, Weisberg AS, Lebowitz J, Heuser J, Moss B (2005) External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice. J Cell Biol 170: 971-981.
59. Heuser J (2005) Deep-etch EM reveals that the early poxvirus envelope is a single membrane bilayer stabilized by a geodetic ''honeycomb'' surface coat. J Cell Biol 169: 269-283.
60. Huang RH, Wang Y, Roth R, Yu X, Purvis AR, et al. (2008) Assembly of Weibel-Palade body-like tubules from N-terminal domains of von Willebrand factor. Proc Natl Acad Sci U S A 105: 482-487.
61. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, et al. (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11: 936-943.
62. Yuan H, Barnes KR, Weissleder R, Cantley L, Josephson L (2007) Covalent reactions of wortmannin under physiological conditions. Chem Biol 14: 321-328.
63. Woscholski R, Kodaki T, McKinnon M, Waterfield MD, Parker PJ (1994) A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase. FEBS Lett 342: 109-114.
64. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, et al. (1994) Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54: 2419-2423.
65. Stein RC, Waterfield MD (2000) PI3-kinase inhibition: a target for drug development? Mol Med Today 6: 347-357.
66. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, et al. (1998) Regulation of the p85/p110 phosphatidylinositol 39-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18: 1379-1387.
67. Zaborowska I, Walsh D (2009) PI3K signaling regulates rapamycin-insensitive translation initiation complex formation in Vaccinia Virus-infected cells. J Virol.
68. Ericsson M, Cudmore S, Shuman S, Condit RC, Griffiths G, et al. (1995) Characterization of ts 16, a temperature-sensitive mutant of vaccinia virus. J Virol 69: 7072-7086.
69. Blasco R, Moss B (1991) Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J Virol 65: 5910-5920.
70. Engelstad M, Smith GL (1993) The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194: 627-637.
71. Wolffe EJ, Isaacs SN, Moss B (1993) Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol 67: 4732-4741.
72. Sung TC, Roper RL, Zhang Y, Rudge SA, Temel R, et al. (1997) Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity. EMBO J 16: 4519-4530.
73. Roper RL, Moss B (1999) Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein. J Virol 73: 1108-1117.
74. Moss B, Rosenblum EN, Katz E, Grimley PM (1969) Rifampicin: a specific inhibitor of vaccinia virus assembly. Nature 224: 1280-1284.
75. Herrera E, Lorenzo MM, Blasco R, Isaacs SN (1998) Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J Virol 72: 294-302.
76. Blasco R, Sisler JR, Moss B (1993) Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J Virol 67: 3319-3325.
77. Dales S (1965) Replication of Animal Viruses as Studied by Electron Microscopy. Am J Med 38: 699-715.
78. Hu N, Yu R, Shikuma C, Shiramizu B, Ostrwoski MA, et al. (2009) Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells. Vaccine 27: 2994-3006.
79. Assarsson E, Greenbaum JA, Sundstrom M, Schaffer L, Hammond JA, et al. (2008) Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci USA 105: 2140-2145.
80. Condit RC, Niles EG (2002) Regulation of viral transcription elongation and termination during vaccinia virus infection. Biochim Biophys Acta 1577: 325-336.
81. Pedersen K, Snijder EJ, Schleich S, Roos N, Griffiths G, et al. (2000) Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structure. J Virol 74: 3525-3536.
82. Holowczak JA (1972) Uncoating of poxviruses. I. Detection and characterization of subviral particles in the uncoating process. Virology 50: 216-232.
83. Joklik WK (1964) The Intracellular Uncoating of Poxvirus DNA. Ii. The Molecular Basis of the Uncoating Process. J Mol Biol 8: 277-288.
84. Mallardo M, Leithe E, Schleich S, Roos N, Doglio L, et al. (2002) Relationship between vaccinia virus intracellular cores, early mRNAs, and DNA replication sites. J Virol 76: 5167-5183.
85. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, et al. (2002) Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest 109: 141-149.
86. Husain M, Moss B (2002) Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D. J Virol 76: 7777-7789.
87. Ward BM, Moss B (2000) Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein. J Virol 74: 3771-3780.
88. Hiller G, Eibl H, Weber K (1981) Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release. J Virol 39: 903-913.
89. Payne LG, Kristenson K (1979) Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine. J Virol 32: 614-622.
90. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci 30: 194-204.
91. Swimm A, Bommarius B, Li Y, Cheng D, Reeves P, et al. (2004) Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol Biol Cell 15: 3520-3529.
92. Bommarius B, Maxwell D, Swimm A, Leung S, Corbett A, et al. (2007) Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation. Mol Microbiol 63: 1748-1768.
93. Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA (2008) Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog 4: e1000141.
94. Chaussade C, Rewcastle GW, Kendall JD, Denny WA, Cho K, et al. (2007) Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J 404: 449-458.
95. Scott CC, Cuellar-Mata P, Matsuo T, Davidson HW, Grinstein S (2002) Role of 3-phosphoinositides in the maturation of Salmonella-containing vacuoles within host cells. J Biol Chem 277: 12770-12776.
96. Mallo GV, Espina M, Smith AC, Terebiznik MR, Aleman A, et al. (2008) SopB promotes phosphatidylinositol 3-phosphate formation on Salmonella vacuoles by recruiting Rab5 and Vps34. J Cell Biol 182: 741-752.
97. Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V (2001) Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol 154: 631-644.
98. Weiner OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, et al. (2002) A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol 4: 509-513.
99. Lindmo K, Stenmark H (2006) Regulation of membrane traffic by phosphoinositide 3-kinases. J Cell Sci 119: 605-614.
100. Stenmark H, Gillooly DJ (2001) Intracellular trafficking and turnover of phosphatidylinositol 3-phosphate. Semin Cell Dev Biol 12: 193-199.
101. Cluett EB, Kuismanen E, Machamer CE (1997) Heterogeneous distribution of the unusual phospholipid semilysobisphosphatidic acid through the Golgi complex. Mol Biol Cell 8: 2233-2240.
102. Cluett EB, Machamer CE (1996) The envelope of vaccinia virus reveals an unusual phospholipid in Golgi complex membranes. J Cell Sci 109 (Pt 8): 2121-2131.
103. Chamberlain MD, Berry TR, Pastor MC, Anderson DH (2004) The p85alpha subunit of phosphatidylinositol 39-kinase binds to and stimulates the GTPase activity of Rab proteins. J Biol Chem 279: 48607-48614.
104. Shin HW, Hayashi M, Christoforidis S, Lacas-Gervais S, Hoepfner S, et al. (2005) An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol 170: 607-618.
105. Martinez O, Goud B (1998) Rab proteins. Biochim Biophys Acta 1404: 101-112.
106. Krijnse-Locker J, Schleich S, Rodriguez D, Goud B, Snijder EJ, et al. (1996) The role of a 21-kDa viral membrane protein in the assembly of vaccinia virus from the intermediate compartment. J Biol Chem 271: 14950-14958.
107. Chen Y, Honeychurch KM, Yang G, Byrd CM, Harver C, et al. (2009) Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis. Virol J 6: 44.
108. Hayakawa M, Kaizawa H, Moritomo H, Koizumi T, Ohishi T, et al. (2006) Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem 14: 6847-6858.